Abstract
The infrastructure is now in place for bioinformatics to launch drug discovery on a new growth curve.
References
Drews, J. 1996.Nature Biotechnology 14:1516–1518.
The Wilkerson Group recently completed the white paper "Assessment of Informatics Needs and Productivity Bottlenecks in Drug Discovery.".
Acknowledgements
We would like to acknowledge the help of Judy Korman and George Farrington, managing directors at The Wilkerson Group, for their comments and contributions to this article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Larvol, B., Wilkerson, L. In silico drug discovery: Tools for bridging the NCE gap. Nat Biotechnol 16 (Suppl 1), 33–34 (1998). https://doi.org/10.1038/5412
Issue Date:
DOI: https://doi.org/10.1038/5412
- Springer Nature America, Inc.